Skip to content

Methohexital

Barbiturate — NERVOUS SYSTEM

Also known as: brevital sodium, enallynymall, methodrexitone, methohexital sodium, methohexitone, metoesital

OfpFDA approvedATC N01AF01ATC N05CA15

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Methohexital is an ofp drug in the Barbiturate class catalogued in DrugCentral. It was first approved by the FDA in 1960. DrugCentral lists 3 molecular targets, including GLRA1, GABRA1|GABRG2|GABRB3 and CHRNB2|CHRNA2. Recorded indications include General anesthesia and Local anesthesia.

  • Approval status: ofp (first approved 1960 by the FDA).
  • Drug class: Barbiturate.
  • Molecular targets: GLRA1, GABRA1|GABRG2|GABRB3 and CHRNB2|CHRNA2 (3 listed in DrugCentral).
  • Indications: General anesthesia and Local anesthesia.
  • ATC code: N01AF01 (Barbiturates, plain).
  • Molecular formula: C14H18N2O3; molecular weight 262.31 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • General anesthesia
  • Local anesthesia

Contraindications (12)

  • Anemia
  • Asthma
  • Chronic heart failure
  • Chronic obstructive lung disease
  • Hepatic failure
  • Hypertensive urgency
  • Kidney disease
  • Low blood pressure
  • Morbid obesity
  • Porphyria
  • Seizure disorder
  • Shock

Mechanism & targets

Established pharmacologic classBarbiturate

Molecular targets (3)

TargetGeneActionActivity
Glycine receptor subunit alpha-1GLRA1unknown—
GABA-A receptor alpha-1/beta-3/gamma-2GABRA1|GABRG2|GABRB3positive allosteric modulator—
Neuronal acetylcholine receptor; alpha2/beta2CHRNB2|CHRNA2unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1960-06-27FDA—PAR STERILE PRODUCTS

ATC classification

ATC codeTherapeutic hierarchy
N01AF01NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, GENERAL › Barbiturates, plain
N05CA15NERVOUS SYSTEM › PSYCHOLEPTICS › HYPNOTICS AND SEDATIVES › Barbiturates, plain

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Methohexital is on its molecule page.

Molecular formulaC14H18N2O3
Molecular weight262.31 g/mol
CAS number151-83-7
InChIKeyNZXKDOXHBHYTKP-UHFFFAOYSA-N
PubChem CID9034
CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Methohexital used for?

DrugCentral lists the following indications for Methohexital: General anesthesia and Local anesthesia.

How does Methohexital work?

Its molecular targets in DrugCentral include GLRA1, GABRA1|GABRG2|GABRB3 (positive allosteric modulator) and CHRNB2|CHRNA2.

When was Methohexital first approved?

Methohexital was first approved by the FDA in 1960.

What drug class does Methohexital belong to?

Methohexital is in the Barbiturate class.

What is the chemical formula of Methohexital?

Methohexital has the molecular formula C14H18N2O3 and a molecular weight of 262.31 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1960-06-27
AgencyFDA
Targets3
Indications2
FormulaC14H18N2O3
DrugCentral ID1748
Interactive profile